Prologue Journal

Sanofi to Buy Rare-Disease Assets From Inhibrx

• prologu5
• 01/23/202401/23/2024

Wall Street Journal

Sanofi plans to buy assets from U.S. biopharmaceutical company Inhibrx in a deal valued at up to $2.2 billion.

https://www.wsj.com/articles/sanofi-to-buy-assets-from-inhibrx-in-deal-valued-at-up-to-2-2-billion-658407ad